FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2165233269> ?p ?o ?g. }

• W2165233269 endingPage "830" @default.
• W2165233269 startingPage "824" @default.
• W2165233269 abstract "Abstract Learning Objectives After completing this course, the reader will be able to: Describe the pathogenesis of AL amyloidosis.Identify other disorders often associated with AL amyloidosis.Discuss the importance of the prompt diagnosis and treatment of AL amyloidosis and any underlying plasma cell disorder.Identify presenting signs and symptoms that should lead to the suspicion of AL amyloidosis. Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com Primary (AL) amyloidosis is the most common form of systemic amyloidosis. The morbidity arises from extracellular deposition of immunoglobulin light chain (LC) fibrils in major organs, such as the kidneys, heart, and bowel. Organ dysfunction contributes to a high mortality and poor prognosis, with a median survival time of 1–2 years from diagnosis. Here, we present a 46-year-old man with an exceptional clinical course of an LC multiple myeloma with generalized amyloidosis, causing renal insufficiency, congestive heart failure, and complete intestinal necrosis. We have summarized recent knowledge on AL amyloidosis, its association with monoclonal gammopathies, clinical presentations, diagnostic tools, and treatment strategies. Our comprehensive overview of this rare and often fatal disease aims to increase the awareness of AL amyloidosis. This may facilitate earlier diagnosis, and thus allow initiation of prompt and specific therapies, which are indispensable in order to improve disease prognosis." @default.
• W2165233269 created "2016-06-24" @default.
• W2165233269 creator A5008206072 @default.
• W2165233269 creator A5025125007 @default.
• W2165233269 creator A5028960469 @default.
• W2165233269 creator A5036859964 @default.
• W2165233269 creator A5045306551 @default.
• W2165233269 creator A5057117005 @default.
• W2165233269 creator A5081704124 @default.
• W2165233269 date "2006-07-01" @default.
• W2165233269 modified "2023-10-18" @default.
• W2165233269 title "Primary (AL) Amyloidosis in Plasma Cell Disorders" @default.
• W2165233269 cites W1955975006 @default.
• W2165233269 cites W1975039732 @default.
• W2165233269 cites W1976598591 @default.
• W2165233269 cites W1977150379 @default.
• W2165233269 cites W1980881602 @default.
• W2165233269 cites W1988200781 @default.
• W2165233269 cites W2003556068 @default.
• W2165233269 cites W2008182609 @default.
• W2165233269 cites W2022988413 @default.
• W2165233269 cites W2034053702 @default.
• W2165233269 cites W2055317154 @default.
• W2165233269 cites W2059494778 @default.
• W2165233269 cites W206392377 @default.
• W2165233269 cites W2063939741 @default.
• W2165233269 cites W2073595362 @default.
• W2165233269 cites W2074136477 @default.
• W2165233269 cites W2083150508 @default.
• W2165233269 cites W2086988386 @default.
• W2165233269 cites W2091692010 @default.
• W2165233269 cites W2107403553 @default.
• W2165233269 cites W2117758623 @default.
• W2165233269 cites W2125709144 @default.
• W2165233269 cites W2144506100 @default.
• W2165233269 cites W2147030264 @default.
• W2165233269 cites W2164807675 @default.
• W2165233269 cites W2275140702 @default.
• W2165233269 cites W2316718219 @default.
• W2165233269 cites W2319723388 @default.
• W2165233269 cites W2588941643 @default.
• W2165233269 doi "https://doi.org/10.1634/theoncologist.11-7-824" @default.
• W2165233269 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16880241" @default.
• W2165233269 hasPublicationYear "2006" @default.
• W2165233269 type Work @default.
• W2165233269 sameAs 2165233269 @default.
• W2165233269 citedByCount "28" @default.
• W2165233269 countsByYear W21652332692012 @default.
• W2165233269 countsByYear W21652332692013 @default.
• W2165233269 countsByYear W21652332692014 @default.
• W2165233269 countsByYear W21652332692015 @default.
• W2165233269 countsByYear W21652332692016 @default.
• W2165233269 countsByYear W21652332692017 @default.
• W2165233269 countsByYear W21652332692019 @default.
• W2165233269 countsByYear W21652332692022 @default.
• W2165233269 countsByYear W21652332692023 @default.
• W2165233269 crossrefType "journal-article" @default.
• W2165233269 hasAuthorship W2165233269A5008206072 @default.
• W2165233269 hasAuthorship W2165233269A5025125007 @default.
• W2165233269 hasAuthorship W2165233269A5028960469 @default.
• W2165233269 hasAuthorship W2165233269A5036859964 @default.
• W2165233269 hasAuthorship W2165233269A5045306551 @default.
• W2165233269 hasAuthorship W2165233269A5057117005 @default.
• W2165233269 hasAuthorship W2165233269A5081704124 @default.
• W2165233269 hasBestOaLocation W21652332691 @default.
• W2165233269 hasConcept C126322002 @default.
• W2165233269 hasConcept C142724271 @default.
• W2165233269 hasConcept C159654299 @default.
• W2165233269 hasConcept C177713679 @default.
• W2165233269 hasConcept C203014093 @default.
• W2165233269 hasConcept C2776364478 @default.
• W2165233269 hasConcept C2776396001 @default.
• W2165233269 hasConcept C2777633098 @default.
• W2165233269 hasConcept C2778198053 @default.
• W2165233269 hasConcept C2778797674 @default.
• W2165233269 hasConcept C2779134260 @default.
• W2165233269 hasConcept C2779551797 @default.
• W2165233269 hasConcept C2779951007 @default.
• W2165233269 hasConcept C2779962030 @default.
• W2165233269 hasConcept C36394416 @default.
• W2165233269 hasConcept C71924100 @default.
• W2165233269 hasConceptScore W2165233269C126322002 @default.
• W2165233269 hasConceptScore W2165233269C142724271 @default.
• W2165233269 hasConceptScore W2165233269C159654299 @default.
• W2165233269 hasConceptScore W2165233269C177713679 @default.
• W2165233269 hasConceptScore W2165233269C203014093 @default.
• W2165233269 hasConceptScore W2165233269C2776364478 @default.
• W2165233269 hasConceptScore W2165233269C2776396001 @default.
• W2165233269 hasConceptScore W2165233269C2777633098 @default.
• W2165233269 hasConceptScore W2165233269C2778198053 @default.
• W2165233269 hasConceptScore W2165233269C2778797674 @default.
• W2165233269 hasConceptScore W2165233269C2779134260 @default.
• W2165233269 hasConceptScore W2165233269C2779551797 @default.
• W2165233269 hasConceptScore W2165233269C2779951007 @default.
• W2165233269 hasConceptScore W2165233269C2779962030 @default.
• W2165233269 hasConceptScore W2165233269C36394416 @default.
• W2165233269 hasConceptScore W2165233269C71924100 @default.
• W2165233269 hasIssue "7" @default.

• next